Shares of MeiraGTx Holdings PLC MGTX, -4.88% jumped 14% premarket on Monday after the gene therapy company announced that French drugmaker Sanofi SNY, -19.13% has made a $30 million investment.
MeiraGTx has also been approached by multiple parties with strategic interest in various company assets and is “actively pursuing these options,” the company said in the release. The investment comes a few months after Sanofi expanded an earlier gene-therapy collaboration with Scribe Therapeutics Inc., licensing Scribe’s gene editing technology for development of in vivo therapies, including sickle cell disease.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: axios - 🏆 302. / 63 Read more »
Source: FoxNews - 🏆 9. / 87 Read more »